Current Aspects in the Biology, Pathogeny, and Treatment of Candida krusei, a Neglected Fungal Pathogen

References

• Klingspor L, Tortorano AM, Peman J, et al. Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006–2008). Clin Microbiol Infect. 2015;21(1):87.e81-87.e10. doi:10.1016/j.cmi.2014.08.011
   Google Scholar
• Andes DR, Safdar N, Baddley JW, et al. The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Transpl Infect Dis. 2016;18(6):921–931. doi:10.1111/tid.1261327643395
   PubMed Web of Science ®Google Scholar
• Cornely OA. on behalf of the EIDG, Gachot B, et al. Epidemiology and outcome of fungemia in a cancer cohort of the infectious diseases group (IDG) of the european organization for research and treatment of cancer (EORTC 65031). Clin Infect Dis. 2015;61(3):324–331. doi:10.1093/cid/civ29325870323
   PubMed Web of Science ®Google Scholar
• Viscoli C, Girmenia C, Marinus A, et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis. 1999;28(5):1071–1079. doi:10.1086/51473110452637
   PubMed Web of Science ®Google Scholar
• Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med. 2002;113(6):480–485. doi:10.1016/S0002-9343(02)01248-212427497
   PubMed Web of Science ®Google Scholar
• Eliakim-Raz N, Babaoff R, Yahav D, Yanai S, Shaked H, Bishara J. Epidemiology, microbiology, clinical characteristics, and outcomes of candidemia in internal medicine wards—a retrospective study. Int J Infect Dis. 2016;52:49–54. doi:10.1016/j.ijid.2016.09.01827663909
   PubMed Web of Science ®Google Scholar
• Lass-Flörl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses. 2009;52(3):197–205. doi:10.1111/j.1439-0507.2009.01691.x19391253
   PubMed Web of Science ®Google Scholar
• Tan TY, Tan AL, Tee NWS, Ng LSY, Chee CWJ. The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study. Mycoses. 2010;53(6):515–521. doi:10.1111/j.1439-0507.2009.01746.x19619263
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Boyken L, Hollis RJ, Messer SA, Tendolkar S, Diekema DJ. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole. J Clin Microbiol. 2005;43(11):5425–5427. doi:10.1128/JCM.43.11.5425-5427.200516272464
   PubMed Web of Science ®Google Scholar
• Pfaller Michael A, Pappas Peter G, Wingard John R. Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis. 2006;43(S1):S3–S14. doi:10.1086/504490
   Web of Science ®Google Scholar
• Tortorano AM, Kibbler C, Peman J, Bernhardt H, Klingspor L, Grillot R. Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents. 2006;27(5):359–366. doi:10.1016/j.ijantimicag.2006.01.00216647248
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Bischoff T, Tallent Sandra M, Seifert H, Wenzel Richard P, Edmond Michael B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309–317. doi:10.1086/42194615306996
   PubMed Web of Science ®Google Scholar
• Samaranayake YH, Samaranayake LP. Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen. J Med Microbiol. 1994;41(5):295–310. doi:10.1099/00222615-41-5-2957966200
   PubMed Web of Science ®Google Scholar
• Samaranayake YH, Wu PC, Samaranayake LP, PL HO. The relative pathogenicity of Candida Krusei and C. albicans in the rat oral mucosa. J Med Microbiol. 1998;47(12):1047–1057. doi:10.1099/00222615-47-12-10479856640
   PubMed Web of Science ®Google Scholar
• Fleischmann J, Broeckling CD, Lyons S. Candida krusei form mycelia along agar surfaces towards each other and other Candida species. BMC Microbiol. 2017;17(1):60. doi:10.1186/s12866-017-0972-z28284180
   PubMed Web of Science ®Google Scholar
• Toth R, Nosek J, Mora-Montes HM, et al. Candida parapsilosis: from genes to the bedside. Clin Microbiol Rev. 2019;32:2.
   Web of Science ®Google Scholar
• Zheng Q, Zhang Q, Bing J, Ding X, Huang G. Environmental and genetic regulation of white-opaque switching in. Candida Tropicalis. Mol Microbiol. 2017;106(6):999–1017. doi:10.1111/mmi.1386229030879
   PubMed Web of Science ®Google Scholar
• Soll DR. The role of phenotypic switching in the basic biology and pathogenesis of Candida albicans. J Oral Microbiol. 2014;6(1):22993. doi:10.3402/jom.v3406.22993
   PubMed Web of Science ®Google Scholar
• Joshi KR, Wheeler EE, Gavin JB. The ultrastructure of Candida krusei Candida krusei. Mycopathologia. 1975;56(1):5–8. doi:10.1007/BF0493575807847
   PubMed Web of Science ®Google Scholar
• Navarro-Arias MJ, Hernandez-Chavez MJ, Garcia-Carnero LC, et al. Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells. Infect Drug Resist. 2019;12:783–794. doi:10.2147/IDR.S19753131040708
   PubMed Web of Science ®Google Scholar
• Kogan G, Pavliak V, Sandula J, Masler L. Novel structure of the cellular mannan of the pathogenic yeast Candida krusei. Carbohydr Res. 1988;184:171–182. doi:10.1016/0008-6215(88)80015-63149545
   PubMed Web of Science ®Google Scholar
• Mora-Montes HM, Ponce-Noyola P, Villagómez-Castro JC, Gow NAR, Flores-Carreón A, López-Romero E. Protein glycosylation in Candida. Future Microbiol 2009;4(9):1167–1183. doi:10.2217/fmb.09.8819895219
   PubMed Web of Science ®Google Scholar
• Kuraoka T, Ishiyama A, Oyamada H, Ogawa Y, Kobayashi H. Presence of O-glycosidically linked oligosaccharides in the cell wall mannan of Candida krusei purified with Benanomicin A. FEBS Open Bio. 2018;9(1):129–136. doi:10.1002/2211-5463.12558
   Web of Science ®Google Scholar
• Diaz-Jimenez DF, Mora-Montes HM, Hernandez-Cervantes A, Luna-Arias JP, Gow NA, Flores-Carreon A. Biochemical characterization of recombinant Candida albicans mannosyltransferases Mnt1, Mnt2 and Mnt5 reveals new functions in O- and N-mannan biosynthesis. Biochem Biophys Res Commun. 2012;419(1):77–82. doi:10.1016/j.bbrc.2012.01.13122326920
   PubMed Web of Science ®Google Scholar
• Serrano-Fujarte I, Lopez-Romero E, Cuellar-Cruz M. Moonlight-like proteins of the cell wall protect sessile cells of Candida from oxidative stress. Microb Pathog. 2016;90:22–33. doi:10.1016/j.micpath.2015.10.00126550764
   PubMed Web of Science ®Google Scholar
• Vecchione A, Florio W, Celandroni F, Barnini S, Lupetti A, Ghelardi E. Comparative evaluation of six chromogenic media for presumptive yeast identification. J Clin Pathol. 2017;70(12):1074–1078. doi:10.1136/jclinpath-2017-20439628663328
   PubMed Web of Science ®Google Scholar
• Liu HJ, Liu DH, Zhong JJ. Novel fermentation strategy for enhancing glycerol production by Candida krusei. Biotechnol Prog. 2003;19(5):1615–1619. doi:10.1021/bp034097f14524727
   PubMed Web of Science ®Google Scholar
• Greppi A, Rantisou K, Padonou W, et al. Yeast dynamics during spontaneous fermentation of mawè and tchoukoutou, two traditional products from Benin. Int J Food Microbiol. 2013;165(2):200–207. doi:10.1016/j.ijfoodmicro.2013.05.00423756236
   PubMed Web of Science ®Google Scholar
• Omemu AM, Oyewole OB, Bankole MO. Significance of yeasts in the fermentation of maize for ogi production. Food Microbiol. 2007;24(6):571–576. doi:10.1016/j.fm.2007.01.00617418307
   PubMed Web of Science ®Google Scholar
• Halm M, Hornbæk T, Arneborg N, Sefa-Dedeh S, Jespersen L. Lactic acid tolerance determined by measurement of intracellular pH of single cells of Candida krusei and Saccharomyces cerevisiae isolated from fermented maize dough. Int J Food Microbiol. 2004;94(1):97–103. doi:10.1016/j.ijfoodmicro.2003.12.01915172490
   PubMed Web of Science ®Google Scholar
• Randhawa HS, Mussa AY, Khan ZU. Decaying wood in tree trunk hollows as a natural substrate for Cryptococcus neoformans and other yeast-like fungi of clinical interest. Mycopathologia. 2001;151(2):63–69. doi:10.1023/A:101090622088811554580
   PubMed Web of Science ®Google Scholar
• Bernard EM, Christiansen KJ, Tsang SF, Kiehn TE, Armstrong D. Rate of arabinitol production by pathogenic yeast species. J Clin Microbiol. 1981;14(2):189–194. doi:10.1128/JCM.14.2.189-194.19817024306
   PubMed Web of Science ®Google Scholar
• Cuomo CA, Shea T, Yang B, Rao R, Forche A. Whole genome sequence of the heterozygous clinical isolate Candida krusei 81-B-5. G3 (Bethesda). 2017;7(9):2883–2889.
   Google Scholar
• Jacobsen MD, Gow NAR, Maiden MCJ, Shaw DJ, Odds FC. Strain typing and determination of population structure of Candida krusei by multilocus sequence typing. J Clin Microbiol. 2007;45(2):317–323. doi:10.1128/JCM.01549-0617122025
   PubMed Web of Science ®Google Scholar
• Douglass AP, Offei B, Braun-Galleani S, et al. Population genomics shows no distinction between pathogenic Candida krusei and environmental Pichia kudriavzevii: one species, four names. PLoS Pathog. 2018;14(7):e1007138–e1007138. doi:10.1371/journal.ppat.100713830024981
   PubMed Web of Science ®Google Scholar
• Butler G, Rasmussen MD, Lin MF, et al. Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature. 2009;459(7247):657–662. doi:10.1038/nature0806419465905
   PubMed Web of Science ®Google Scholar
• Estrada-Mata E, Navarro-Arias MJ, Perez-Garcia LA, et al. Members of the Candida parapsilosis complex and Candida albicans are differentially recognized by human peripheral blood mononuclear cells. Front Microbiol. 2015;6:1527.26793173
   PubMed Web of Science ®Google Scholar
• Navarro-Arias MJ, Defosse TA, Dementhon K, et al. Disruption of protein mannosylation affects Candida guilliermondii cell wall, immune sensing, and virulence. Front Microbiol. 2016;7:1951. doi:10.3389/fmicb.2016.0195127994582
   PubMed Web of Science ®Google Scholar
• Perez-Garcia LA, Csonka K, Flores-Carreon A, et al. Role of protein glycosylation in Candida parapsilosis cell wall integrity and host interaction. Front Microbiol. 2016;7:306. doi:10.3389/fmicb.2016.0030627014229
   PubMed Web of Science ®Google Scholar
• Koga-Ito CY, Komiyama EY, de Paiva Martins CA, et al. Experimental systemic virulence of oral Candida dubliniensis isolates in comparison with Candida albicans, Candida tropicalis and Candida krusei. Mycoses. 2011;54(5):e278–e285. doi:10.1111/j.1439-0507.2010.01899.x20492535
   PubMed Web of Science ®Google Scholar
• Anaissie E, Hachem R, Tin-U C, Stephens LC, Bodey GP. Experimental hematogenous candidiasis caused by Candida krusei and Candida albicans: species differences in pathogenicity. Infect Immun. 1993;61(4):1268–1271. doi:10.1128/IAI.61.4.1268-1271.19938454330
   PubMed Web of Science ®Google Scholar
• Ortega-Riveros M, De-la-Pinta I, Marcos-Arias C, Ezpeleta G, Quindós G, Eraso E. Usefulness of the non-conventional Caenorhabditis elegans model to assess Candida virulence. Mycopathologia. 2017;182(9):785–795. doi:10.1007/s11046-017-0142-828523422
   PubMed Web of Science ®Google Scholar
• Aguiar Cordeiro R, de Jesus Evangelista AJ, Serpa R, et al. β-lactam antibiotics & vancomycin increase the growth & virulence of Candida spp. Future Microbiol. 2018;13(8):869–875. doi:10.2217/fmb-2018-001929882422
   PubMed Web of Science ®Google Scholar
• Silva LN, Campos-Silva R, Ramos LS, et al. Virulence of Candida haemulonii complex in Galleria mellonella and efficacy of classical antifungal drugs: a comparative study with other clinically relevant non-albicans Candida species. FEMS Yeast Res. 2018;18(7):foy082. doi:10.1093/femsyr/foy082
   Web of Science ®Google Scholar
• Marcos-Zambrano LJ, Bordallo-Cardona MÁ, Borghi E, et al. Candida isolates causing candidemia show different degrees of virulence in Galleria mellonella. Med Mycol. 2020;58(1):83–92. doi:10.1093/mmy/myz02730874807
   PubMed Web of Science ®Google Scholar
• Santos RB, Scorzoni L, Namba AM, Rossoni RD, Jorge AOC, Junqueira JC. Lactobacillus species increase the survival of Galleria mellonella infected with Candida albicans and non–albicans Candida clinical isolates. Med Mycol. 2018;57(3):391–394. doi:10.1093/mmy/myy032
   Web of Science ®Google Scholar
• Chamilos G, Lionakis MS, Lewis RE, et al. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. J Infect Dis. 2006;193(7):1014–1022. doi:10.1086/50095016518764
   PubMed Web of Science ®Google Scholar
• Ellepola ANB, Panagoda GJ, Samaranayake LP. Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin. Oral Microbiol Immunol. 1999;14(6):358–363. doi:10.1034/j.1399-302X.1999.140605.x10895691
   PubMedGoogle Scholar
• Klotz SA, Drutz DJ, Harrison JL, Huppert M. Adherence and penetration of vascular endothelium by Candida yeasts. Infect Immun. 1983;42(1):374–384. doi:10.1128/IAI.42.1.374-384.19836352500
   PubMed Web of Science ®Google Scholar
• Samaranayake YH, Wu PC, Samaranayake LP, So M, Yuen KY. Adhesion and colonisation of Candida krusei on host surfaces. J Med Microbiol. 1994;41(4):250–258. doi:10.1099/00222615-41-4-2507932617
   PubMed Web of Science ®Google Scholar
• Arzmi MH, Abdul Razak F, Yusoff Musa M, Wan Harun WHA. Effect of phenotypic switching on the biological properties and susceptibility to chlorhexidine in Candida krusei ATCC 14243. FEMS Yeast Res. 2012;12(3):351–358. doi:10.1111/j.1567-1364.2011.00786.x22225549
   PubMed Web of Science ®Google Scholar
• Li F, Palecek SP. EAP1, a Candida albicans gene involved in binding human epithelial cells. Eukaryot Cell. 2003;2(6):1266–1273. doi:10.1128/EC.2.6.1266-1273.200314665461
   PubMedGoogle Scholar
• Kempf M, Apaire-Marchais V, Saulnier P, et al. Disruption of Candida albicans IFF4 gene involves modifications of the cell electrical surface properties. Colloids Surf B: Biointerfaces. 2007;58(2):250–255. doi:10.1016/j.colsurfb.2007.03.01717481864
   PubMed Web of Science ®Google Scholar
• Sandini S, La Valle R, De Bernardis F, Macrì C, Cassone A. The 65 kDa mannoprotein gene of Candida albicans encodes a putative β-glucanase adhesin required for hyphal morphogenesis and experimental pathogenicity. Cell Microbiol. 2007;9(5):1223–1238. doi:10.1111/j.1462-5822.2006.00862.x17217426
   PubMed Web of Science ®Google Scholar
• Calderon J, Zavrel M, Ragni E, Fonzi WA, Rupp S, Popolo L. PHR1, a pH-regulated gene of Candida albicans encoding a glucan-remodelling enzyme, is required for adhesion and invasion. Microbiology. 2010;156(8):2484–2494. doi:10.1099/mic.0.038000-020430812
   PubMed Web of Science ®Google Scholar
• Gale CA, Bendel CM, McClellan M, et al. Linkage of adhesion, filamentous growth, and virulence in Candida albicans; to a single gene INT1. Science. 1998;279(5355):1355–1358. doi:10.1126/science.279.5355.13559478896
   PubMed Web of Science ®Google Scholar
• Martinez-Lopez R, Park H, Myers CL, Gil C, Filler SG. Candida albicans Ecm33p is important for normal cell wall architecture and interactions with host cells. Eukaryot Cell. 2006;5(1):140–147. doi:10.1128/EC.5.1.140-147.200616400176
   PubMedGoogle Scholar
• Hoyer LL. The ALS gene family of Candida albicans. Trends Microbiol. 2001;9(4):176–180. doi:10.1016/S0966-842X(01)01984-911286882
   PubMed Web of Science ®Google Scholar
• Samaranayake YH, Wu PC, Samaranayake LP, So M. Relationship between the cell surface hydrophobicity and adherence of Candida krusei and Candida albicans to epithelial and denture acrylic surfaces. APMIS. 1995;103(7‐8):707–713. doi:10.1111/j.1699-0463.1995.tb01427.x8534429
   PubMed Web of Science ®Google Scholar
• Riceto É, Menezes R, Penatti MPA, Pedroso R. Enzymatic and hemolytic activity in different Candida species. Rev Iberoam Micol. 2015;32(2):79–82. doi:10.1016/j.riam.2013.11.00324704439
   PubMed Web of Science ®Google Scholar
• Pandey N, Gupta MK, Tilak R. Extracellular hydrolytic enzyme activities of the different Candida spp. isolated from the blood of the intensive care unit-admitted patients. J Lab Physicians. 2018;10(4):392–396. doi:10.4103/JLP.JLP_81_1830498309
   PubMed Web of Science ®Google Scholar
• Furlaneto-Maia L, Specian AF, Bizerra FC, de Oliveira MT, Furlaneto MC. In vitro evaluation of putative virulence attributes of oral isolates of Candida spp. obtained from elderly healthy individuals. Mycopathologia. 2008;166(4):209. doi:10.1007/s11046-008-9139-718597183
   PubMed Web of Science ®Google Scholar
• Portela MB, Lima de Amorim E, Santos AM, et al. Candida species from oral cavity of HIV-infected children exhibit reduced virulence factors in the HAART era. Microb Pathog. 2017;102:74–81. doi:10.1016/j.micpath.2016.11.02027913142
   PubMed Web of Science ®Google Scholar
• Leidich SD, Ibrahim AS, Fu Y, et al. Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem. 1998;273(40):26078–26086. doi:10.1074/jbc.273.40.260789748287
   PubMed Web of Science ®Google Scholar
• Sugiyama Y, Nakashima S, Mirbod F, et al. Molecular cloning of a second phospholipase B gene, caPLB2 from Candida albicans. Medical Mycology. 1999;37(1):61–67.10200936
   PubMed Web of Science ®Google Scholar
• Hube B, Stehr F, Bossenz M, Mazur A, Kretschmar M, Schäfer W. Secreted lipases of Candida albicans: cloning, characterisation and expression analysis of a new gene family with at least ten members. Arch Microbiol. 2000;174(5):362–374. doi:10.1007/s00203000021811131027
   PubMed Web of Science ®Google Scholar
• Noumi E, Snoussi M, Noumi I, Saghrouni F, Aouni M, Valentin E. Phenotypic characterization and adhesive properties of vaginal Candida spp. strains provided by the CHU Farhat Hached (Sousse, Tunisia). Rev Iberoam Micol. 2015;32(3):170–179. doi:10.1016/j.riam.2014.06.00625618183
   PubMed Web of Science ®Google Scholar
• Şeker E. Identification of Candida species isolated from bovine mastitic milk and their in vitro hemolytic activity in western Turkey. Mycopathologia. 2010;169(4):303–308.19921462
   PubMed Web of Science ®Google Scholar
• Yigit N, Aktas E, Dagistan S, Ayyildiz A. Investigating biofilm production, coagulase and hemolytic activity in Candida species isolated from denture stomatitis patients. Eurasian J Med. 2011;43(1):27–32. doi:10.5152/eajm.2011.0625610156
   PubMedGoogle Scholar
• Magee BB, Hube B, Wright RJ, Sullivan PJ, Magee PT. The genes encoding the secreted aspartyl proteinases of Candida albicans constitute a family with at least three members. Infect Immun. 1993;61(8):3240–3243. doi:10.1128/IAI.61.8.3240-3243.19938335356
   PubMed Web of Science ®Google Scholar
• White TC, Miyasaki SH, Agabian N. Three distinct secreted aspartyl proteinases in Candida albicans. J Bacteriol. 1993;175(19):6126–6133. doi:10.1128/JB.175.19.6126-6133.19938407785
   PubMed Web of Science ®Google Scholar
• Sánchez-Vargas LO, Estrada-Barraza D, Pozos-Guillen AJ, Rivas-Caceres R. Biofilm formation by oral clinical isolates of Candida species. Arch Oral Biol. 2013;58(10):1318–1326. doi:10.1016/j.archoralbio.2013.06.00623849353
   PubMed Web of Science ®Google Scholar
• Salari S, Sadat Seddighi N, Ghasemi Nejad Almani P. Evaluation of biofilm formation ability in different Candida strains and anti-biofilm effects of Fe3O4-NPs compared with fluconazole: an in vitro study. J Mycol Med. 2018;28(1):23–28. doi:10.1016/j.mycmed.2018.02.00729519624
   PubMed Web of Science ®Google Scholar
• Cao -Y-Y, Cao Y-B, Xu Z, et al. cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob Agents Chemother. 2005;49(2):584–589. doi:10.1128/AAC.49.2.584-589.200515673737
   PubMed Web of Science ®Google Scholar
• Nobile CJ, Mitchell AP. Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol. 2005;15(12):1150–1155. doi:10.1016/j.cub.2005.05.04715964282
   PubMed Web of Science ®Google Scholar
• Nobile CJ, Fox EP, Nett JE, et al. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell. 2012;148(1–2):126–138.22265407
   PubMed Web of Science ®Google Scholar
• Nobile CJ, Nett JE, Hernday AD, et al. Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol. 2009;7(6):e1000133–e1000133. doi:10.1371/journal.pbio.100013319529758
   PubMed Web of Science ®Google Scholar
• Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2):119–128. doi:10.4161/viru.2291323302789
   PubMed Web of Science ®Google Scholar
• Zheng X, Wang Y, Wang Y. Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis. EMBO J. 2004;23(8):1845–1856. doi:10.1038/sj.emboj.760019515071502
   PubMed Web of Science ®Google Scholar
• García-Sánchez S, Mavor AL, Russell CL, et al. Global roles of Ssn6 in Tup1- and Nrg1-dependent gene regulation in the fungal pathogen, Candida albicans. Mol Biol Cell. 2005;16(6):2913–2925. doi:10.1091/mbc.e05-01-007115814841
   PubMed Web of Science ®Google Scholar
• Liu H, Kohler J, Fink G. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science. 1994;266(5191):1723–1726. doi:10.1126/science.79920587992058
   PubMed Web of Science ®Google Scholar
• de Barros PP, Freire F, Rossoni RD, Junqueira JC, Jorge AOC. Candida krusei and Candida glabrata reduce the filamentation of Candida albicans by downregulating expression of HWP1 gene. Folia Microbiol (Praha). 2017;62(4):317–323. doi:10.1007/s12223-017-0500-428164244
   PubMed Web of Science ®Google Scholar
• Kupfahl C, Ruppert T, Dietz A, Geginat G, Hof H. Candida species fail to produce the immunosuppressive secondary metabolite gliotoxin in vitro. FEMS Yeast Res. 2007;7(6):986–992. doi:10.1111/j.1567-1364.2007.00256.x17537180
   PubMed Web of Science ®Google Scholar
• Moyes DL, Wilson D, Richardson JP, et al. Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature. 2016;532(7597):64–68. doi:10.1038/nature1762527027296
   PubMed Web of Science ®Google Scholar
• Botelho NS, de Paula SB, Panagio LA, Pinge-Filho P, Yamauchi LM, Yamada-Ogatta SF. Candida species isolated from urban bats of Londrina-Paraná, Brazil and their potential virulence. Zoonoses Public Health. 2012;59(1):16–22. doi:10.1111/j.1863-2378.2011.01410.x21824363
   PubMed Web of Science ®Google Scholar
• Subramanya SH, Sharan NK, Baral BP, et al. Diversity, in-vitro virulence traits and antifungal susceptibility pattern of gastrointestinal yeast flora of healthy poultry, Gallus gallus domesticus. BMC Microbiol. 2017;17(1):113. doi:10.1186/s12866-017-1024-428506251
   PubMed Web of Science ®Google Scholar
• Brilhante RSN, de Alencar LP, Cordeiro RA, et al. Detection of Candida species resistant to azoles in the microbiota of rheas (Rhea americana): possible implications for human and animal health. J Med Microbiol. 2013;62(Pt 6):889–895. doi:10.1099/jmm.0.055566-023493027
   PubMed Web of Science ®Google Scholar
• Azarvandi A, Khosravi AR, Shokri H, et al. Presence and distribution of yeasts in the reproductive tract in healthy female horses. Equine Vet J. 2017;49(5):614–617. doi:10.1111/evj.1265727931081
   PubMed Web of Science ®Google Scholar
• Martinez-Alvarez JA, Perez-Garcia LA, Flores-Carreon A, Mora-Montes HM. The immune response against Candida spp. and Sporothrix schenckii. Rev Iberoam Micol. 2014;31(1):62–66. doi:10.1016/j.riam.2013.09.01524252829
   PubMed Web of Science ®Google Scholar
• Hernandez-Chavez MJ, Perez-Garcia LA, Nino-Vega GA, Mora-Montes HM. Fungal strategies to evade the host immune recognition. J Fungi (Basel). 2017;3(4):51. doi:10.3390/jof3040051
   Google Scholar
• Gácser A, Tiszlavicz Z, Németh T, Seprényi G, Mándi Y. Induction of human defensins by intestinal Caco-2 cells after interactions with opportunistic Candida species. Microbes Infect. 2014;16(1):80–85. doi:10.1016/j.micinf.2013.09.00324095867
   PubMed Web of Science ®Google Scholar
• Samaranayake YH, Samaranayake LP, Wu PC, So M. The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans. APMIS. 1997;105(7‐12):875–883. doi:10.1111/j.1699-0463.1997.tb05097.x9393559
   PubMed Web of Science ®Google Scholar
• Chen SM, Zou Z, Qiu XR, et al. The critical role of dectin-1 in host controlling systemic Candida krusei infection. Am J Transl Res. 2019;11(2):721–732.30899374
   PubMed Web of Science ®Google Scholar
• Xiong J, Kang K, Liu L, Yoshida Y, Cooper KD, Ghannoum MA. Candida albicans and Candida krusei differentially induce human blood mononuclear cell interleukin-12 and gamma interferon production. Infect Immun. 2000;68(5):2464–2469. doi:10.1128/IAI.68.5.2464-2469.200010768932
   PubMed Web of Science ®Google Scholar
• H⊘gÅsen AKM, Abrahamsen TG, Gaustad P. Various Candida and Torulopsis species differ in their ability to induce the production of C3, factor B and granulocyte-macrophage colony-stimulating factor (GM-CSF) in human monocyte cultures. J Med Microbiol. 1995;42(4):291–298. doi:10.1099/00222615-42-4-2917707338
   PubMed Web of Science ®Google Scholar
• Richardson MD, Donaldson F. Interaction of Candida krusei with human neutrophils in vitro. J Med Microbiol. 1994;41(6):384–388. doi:10.1099/00222615-41-6-3847966213
   PubMed Web of Science ®Google Scholar
• Cunden LS, Gaillard A, Nolan EM. Calcium ions tune the zinc-sequestering properties and antimicrobial activity of human S100A12. Chem Sci. 2016;7(2):1338–1348. doi:10.1039/C5SC03655K26913170
   PubMed Web of Science ®Google Scholar
• Nessa K, Johansson A, Jarstrand C, Camner P. Alveolar macrophage reaction to Candida species. Lett Appl Microbiol. 1997;25(3):181–185. doi:10.1046/j.1472-765X.1997.00200.x9351260
   PubMed Web of Science ®Google Scholar
• García-Rodas R, González-Camacho F, Rodríguez-Tudela JL, Cuenca-Estrella M, Zaragoza O. The interaction between Candida krusei and murine macrophages results in multiple outcomes, including intracellular survival and escape from killing. Infect Immun. 2011;79(6):2136–2144. doi:10.1128/IAI.00044-1121422181
   PubMed Web of Science ®Google Scholar
• Wellington M, Koselny K, Sutterwala FS, Krysan DJ. Candida albicans triggers NLRP3-mediated pyroptosis in macrophages. Eukaryot Cell. 2014;13(2):329–340. doi:10.1128/EC.00336-1324376002
   PubMedGoogle Scholar
• Nguyen TNY, Padungros P, Wongsrisupphakul P, et al. Cell wall mannan of Candida krusei mediates dendritic cell apoptosis and orchestrates Th17 polarization via TLR-2/MyD88-dependent pathway. Sci Rep. 2018;8(1):17123. doi:10.1038/s41598-018-35101-330459422
   PubMed Web of Science ®Google Scholar
• Fidan I, Yesilyurt E, Kalkanci A, et al. Immunomodulatory effects of voriconazole and caspofungin on human peripheral blood mononuclear cells stimulated by Candida albicans and Candida krusei. Am J Med Sci. 2014;348(3):219–223. doi:10.1097/MAJ.000000000000023624662309
   PubMed Web of Science ®Google Scholar
• Li R, Zhang L, Zhang H, et al. Protective effect of a novel antifungal peptide derived from human chromogranin a on the immunity of mice infected with Candida krusei. Exp Ther Med. 2017;13(5):2429–2434. doi:10.3892/etm.2017.429028565859
   PubMed Web of Science ®Google Scholar
• Guinea J. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect. 2014;20:5–10. doi:10.1111/1469-0691.12539
   Web of Science ®Google Scholar
• Labbé A-C, Pépin J, Patiño C, Castonguay S, Restieri C, Laverdiere M. A single-centre 10-year experience with Candida bloodstream infections. Can J Infect Dis Med Microbiol. 2009;20(2):45–50. doi:10.1155/2009/73107020514159
   PubMed Web of Science ®Google Scholar
• Mullen CA, Abd. El-Baki H, Samir H, Tarrand JJ, Rolston KV. Non-albicans Candida is the most common cause of candidemia in pediatric cancer patients. Support Care Cancer. 2003;11(5):321–325. doi:10.1007/s00520-003-0453-912720076
   PubMed Web of Science ®Google Scholar
• Chaudhary U, Goel S, Mittal S. Changing trends of Candidemia and antifungal susceptibility pattern in a tertiary health care centre. Infect Disord Drug Targets. 2015;15(3):171–176. doi:10.2174/187152651566615092811530726411557
   PubMedGoogle Scholar
• Pfaller M, Neofytos D, Diekema D, et al. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008. Diagn Microbiol Infect Dis. 2012;74(4):323–331. doi:10.1016/j.diagmicrobio.2012.10.00323102556
   PubMed Web of Science ®Google Scholar
• Lortholary O, Renaudat C, Sitbon K, et al. The risk and clinical outcome of candidemia depending on underlying malignancy. Intensive Care Med. 2017;43(5):652–662. doi:10.1007/s00134-017-4743-y28321466
   PubMed Web of Science ®Google Scholar
• Ding X, Yan D, Sun W, Zeng Z, Su R, Su J. Epidemiology and risk factors for nosocomial Non-Candida albicans candidemia in adult patients at a tertiary care hospital in North China. Med Mycol. 2015;53(7):684–690. doi:10.1093/mmy/myv06026229153
   PubMed Web of Science ®Google Scholar
• Marco F, Danés C, Almela M, et al. Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. results from a six-year study (1996–2001). Diagn Microbiol Infect Dis. 2003;46(4):259–264. doi:10.1016/S0732-8893(03)00086-512944017
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program. Diagn Microbiol Infect Dis. 1998;30(2):121–129. doi:10.1016/S0732-8893(97)00192-29554180
   PubMed Web of Science ®Google Scholar
• Sabino R, Verissimo C, Brandao J, et al. Epidemiology of candidemia in oncology patients: a 6-year survey in a Portuguese central hospital. Med Mycol. 2010;48(2):346–354. doi:10.3109/1369378090316121619657956
   PubMed Web of Science ®Google Scholar
• Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of candidemia in a tertiary care centre of North India: 5-year study. Infection. 2007;35(4):256–259. doi:10.1007/s15010-007-6144-617646917
   PubMed Web of Science ®Google Scholar
• Chen C-Y, Huang S-Y, Tsay W, et al. Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001–2010. Int J Antimicrob Agents. 2012;40(6):533–538. doi:10.1016/j.ijantimicag.2012.07.02223006521
   PubMed Web of Science ®Google Scholar
• Bukharie HA. Nosocomial candidemia in a tertiary care hospital in Saudi Arabia. Mycopathologia. 2002;153(4):195–198. doi:10.1023/A:101494551779012014479
   PubMed Web of Science ®Google Scholar
• Playford EG, Marriott D, Nguyen Q, et al. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit Care Med. 2008;36(7):2034–2039. doi:10.1097/CCM.0b013e3181760f4218552700
   PubMed Web of Science ®Google Scholar
• Ko J-H, Jung DS, Lee JY, et al. Changing epidemiology of non albicans candidemia in Korea. J Infect Chemother. 2019;25(5):388–391. doi:10.1016/j.jiac.2018.09.01630482698
   PubMed Web of Science ®Google Scholar
• Bonfietti LX, Szeszs MW, Chang MR, et al. Ten-year study of species distribution and antifungal susceptibilities of Candida bloodstream isolates at a Brazilian tertiary hospital. Mycopathologia. 2012;174(5):389–396. doi:10.1007/s11046-012-9566-322821345
   PubMed Web of Science ®Google Scholar
• Dimopoulos G, Ntziora F, Rachiotis G, Armaganidis A, Falagas ME. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg. 2008;106(2):523–529. doi:10.1213/ane.0b013e318160726218227310
   PubMed Web of Science ®Google Scholar
• Papadimitriou-Olivgeris M, Spiliopoulou A, Kolonitsiou F, et al. Increasing incidence of candidaemia and shifting epidemiology in favor of Candida non-albicans in a 9-year period (2009–2017) in a university Greek hospital. Infection. 2019;47(2):209–216. doi:10.1007/s15010-018-1217-230196355
   PubMed Web of Science ®Google Scholar
• Treviño-Rangel R, Peña-López CD, Hernández-Rodríguez PA, Beltrán-Santiago D, González GM. Association between Candida biofilm-forming bloodstream isolates and the clinical evolution in patients with candidemia: an observational nine-year single center study in Mexico. Rev Iberoam Micol. 2018;35(1):11–16. doi:10.1016/j.riam.2017.01.00529287632
   PubMed Web of Science ®Google Scholar
• Marchetti O, Bille J, Fluckiger U, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991–2000. Clin Infect Dis. 2004;38(3):311–320. doi:10.1086/38063714727199
   PubMed Web of Science ®Google Scholar
• Fridkin SK, Kaufman D, Edwards JR, Shetty S, Horan T. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995–2004. Pediatrics. 2006;117(5):1680–1687. doi:10.1542/peds.2005-199616651324
   PubMed Web of Science ®Google Scholar
• Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad I. The changing epidemiology of invasive candidiasis. Cancer. 2008;112(11):2493–2499. doi:10.1002/cncr.2346618412153
   PubMed Web of Science ®Google Scholar
• Sipsas NV, Lewis RE, Tarrand J, et al. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007). Cancer. 2009;115(20):4745–4752. doi:10.1002/cncr.2450719634156
   PubMed Web of Science ®Google Scholar
• Schuster MG, Meibohm A, Lloyd L, Strom B. Risk factors and outcomes of Candida krusei bloodstream infection: A matched, case-control study. J Infect. 2013;66(3):278–284. doi:10.1016/j.jinf.2012.11.00223174708
   PubMed Web of Science ®Google Scholar
• Lin MY, Carmeli Y, Zumsteg J, et al. Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study. Antimicrob Agents Chemother. 2005;49(11):4555–4560. doi:10.1128/AAC.49.11.4555-4560.200516251295
   PubMed Web of Science ®Google Scholar
• Amaral-Lopes S, Moura A. Neonatal fungal sepsis by Candida krusei: A report of three cases and a literature review. Medical Mycol Case Rep. 2012;1(1):24–26. doi:10.1016/j.mmcr.2012.04.002
   Google Scholar
• Prasad PA, Fisher BT, Coffin SE, et al. Pediatric risk factors for candidemia secondary to Candida glabrata and Candida krusei species. J Pediatric Infect Dis Soc. 2013;2(3):263–266. doi:10.1093/jpids/pis09324009984
   PubMedGoogle Scholar
• Fan SR, Liu XP, Li JW. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006. J Obstet and Gynaecol Res. 2008;34(4):561–566. doi:10.1111/j.1447-0756.2008.00817.x18937710
   PubMed Web of Science ®Google Scholar
• Imtiaz T, Thomson F, Innes A, du Toit FC, Bal AM. Candida krusei bronchopneumonia with nodular infiltrates in a patient with chronic renal failure on haemodialysis – case report and review of literature. Mycoses. 2011;54(5):e611–e614. doi:10.1111/j.1439-0507.2010.01925.x20809925
   PubMed Web of Science ®Google Scholar
• Rook GD, Brand D. Candida krusei as a pathogen; case report of an unusual infection of the tonsils. Pediatrics. 1950;6(4):638–643.14786003
   PubMed Web of Science ®Google Scholar
• Lu H, Marengo MF, Mihu CN, Garcia-Manero G, Suarez-Almazor ME. Rare case of septic arthritis caused by Candida krusei: case report and literature review. J Rheumatol. 2012;39(6):1308–1309. doi:10.3899/jrheum.11134822661427
   PubMed Web of Science ®Google Scholar
• Jud P, Valentin T, Regauer S, et al. Invasive Candida krusei infection and Candida vasculitis of a leg ulcer in an immunocompetent patient: a case report. Int J Infect Dis. 2017;55:96–98. doi:10.1016/j.ijid.2017.01.01028104503
   PubMed Web of Science ®Google Scholar
• Multani A, Subramanian AK, Liu AY. Successful eradication of chronic symptomatic Candida krusei urinary tract infection with increased dose micafungin in a liver and kidney transplant recipient: case report and review of the literature. Transpl Infect Dis. 2019;21(4):e13118. doi:10.1111/tid.1311831111613
   PubMed Web of Science ®Google Scholar
• Kano R, Konishi K, Nakata K, et al. Isolation of Candida krusei from a case of bovine bronchopneumonia in a one-year-old heifer. Vet Rec. 2001;148(20):636. doi:10.1136/vr.148.20.63611394804
   PubMed Web of Science ®Google Scholar
• Gaudie CM, Wragg PN, Barber AM. Outbreak of disease due to Candida krusei in a small dairy herd in the UK. Vet Rec. 2009;165(18):535–537. doi:10.1136/vr.165.18.53519880862
   PubMed Web of Science ®Google Scholar
• Sheena A, Sigler L. Candida krusei isolated from a sporadic case of bovine mastitis. Can Vet J. 1995;36(6):365.7648539
   PubMed Web of Science ®Google Scholar
• Seker E. Identification of Candida species isolated from bovine mastitic milk and their in vitro hemolytic activity in Western Turkey. Mycopathologia. 2010;169(4):303–308.19921462
   PubMed Web of Science ®Google Scholar
• Du J, Wang X, Luo H, Wang Y, Liu X, Zhou X. Epidemiological investigation of non-albicans Candida species recovered from mycotic mastitis of cows in Yinchuan, Ningxia of China. BMC Vet Res. 2018;14(1):251. doi:10.1186/s12917-018-1564-330157847
   PubMed Web of Science ®Google Scholar
• Ksouri S, Djebir S, Hadef Y, Benakhla A. Survey of bovine mycotic mastitis in different mammary gland statuses in two north-eastern regions of Algeria. Mycopathologia. 2015;179(3–4):327–331. doi:10.1007/s11046-014-9845-225481847
   PubMed Web of Science ®Google Scholar
• Wawron W, Bochniarz M, Szczubiał M. Enzymatic activity of yeasts isolated from the inflamed mammary secretion in dairy cows. Pol J Vet Sci. 2011;14(1):65–68. doi:10.2478/v10181-011-0009-821528713
   PubMed Web of Science ®Google Scholar
• Boutilier P, Carr A. Fungal colonization and failure of a long-term gastrostomy tube in a cat. Can Vet J. 2005;46(8):709–710.16187714
   PubMed Web of Science ®Google Scholar
• Elad D, Shpigel NY, Winkler M, et al. Feed contamination with Candida krusei as a probable source of mycotic mastitis in dairy cows. J Am Vet Med Assoc. 1995;207(5):620–622.7649779
   PubMed Web of Science ®Google Scholar
• Donnelly KA, Wellehan JFX Jr., Quesenberry K. Gastrointestinal disease associated with non-albicans Candida species in six birds. J Avian Med Surg. 2019;33(4):413–418. doi:10.1647/2018-41931833310
   PubMed Web of Science ®Google Scholar
• Muir M, Raidal SR. Necrotising ventriculitis due to combined infection with Rhizopus microsporus var. chinensis and Candida krusei in an eclectus parrot (Eclectus roratus). Aust Vet J. 2012;90(7):277–280. doi:10.1111/j.1751-0813.2012.00929.x22731951
   PubMed Web of Science ®Google Scholar
• Daef E, Moharram A, Eldin SS, Elsherbiny N, Mohammed M. Evaluation of chromogenic media and seminested PCR in the identification of Candida species. Braz J Microbiol. 2014;45(1):255–262. doi:10.1590/S1517-8382201400500004024948942
   PubMed Web of Science ®Google Scholar
• Baixench MT, Taillandier A, Paugam A. Clinical and experimental evaluation of a new chromogenic medium (OCCA, Oxoid) for direct identification of Candida albicans, C. tropicalis and C. krusei. Mycoses. 2006;49(4):311–315. doi:10.1111/j.1439-0507.2006.01259.x16784446
   PubMed Web of Science ®Google Scholar
• Zhao L, de Hoog GS, Cornelissen A, et al. Prospective evaluation of the chromogenic medium CandiSelect 4 for differentiation and presumptive identification of non-Candida albicans Candida species. Fungal Biol. 2016;120(2):173–178. doi:10.1016/j.funbio.2015.09.00626781374
   PubMed Web of Science ®Google Scholar
• Szabó Z, Tóth B, Kovács M, et al. Evaluation of the new Micronaut-Candida system compared to the API ID32C method for yeast identification. J Clin Microbiol. 2008;46(5):1824–1825. doi:10.1128/JCM.02350-0718322057
   PubMed Web of Science ®Google Scholar
• Meurman O, Koskensalo A, Rantakokko-Jalava K. Evaluation of Vitek 2 for identification of yeasts in the clinical laboratory. Clin Microbiol Infect. 2006;12(6):591–593. doi:10.1111/j.1469-0691.2006.01409.x16700713
   PubMed Web of Science ®Google Scholar
• Hertel M, Hartwig S, Schütte E, et al. Identification of signature volatiles to discriminate Candida albicans, glabrata, krusei and tropicalis using gas chromatography and mass spectrometry. Mycoses. 2016;59(2):117–126. doi:10.1111/myc.1244226667499
   PubMed Web of Science ®Google Scholar
• Morace G, Sanguinetti M, Posteraro B, Lo Cascio G, Fadda G. Identification of various medically important Candida species in clinical specimens by PCR-restriction enzyme analysis. J Clin Microbiol. 1997;35(3):667–672. doi:10.1128/JCM.35.3.667-672.19979041409
   PubMed Web of Science ®Google Scholar
• Maiwald M, Kappe R, Sonntag HG. Rapid presumptive identification of medically relevant yeasts to the species level by polymerase chain reaction and restriction enzyme analysis. J Med Vet Mycol. 1994;32(2):115–122. doi:10.1080/026812194800001618064542
   PubMedGoogle Scholar
• Rezazadeh E, Moazeni M, Sabokbar A. Use of cost effective and rapid molecular tools for identification of Candida species, opportunistic pathogens. Curr Med Mycol. 2016;2(3):1–4. doi:10.18869/acadpub.cmm.2.3.1
   Google Scholar
• Carlotti A, Chaib F, Couble A, Bourgeois N, Blanchard V, Villard J. Rapid identification and fingerprinting of Candida krusei by PCR-based amplification of the species-specific repetitive polymorphic sequence CKRS-1. J Clin Microbiol. 1997;35(6):1337–1343. doi:10.1128/JCM.35.6.1337-1343.19979163440
   PubMed Web of Science ®Google Scholar
• Kanbe T, Horii T, Arishima T, Ozeki M, Kikuchi A. PCR-based identification of pathogenic Candida species using primer mixes specific to Candida DNA topoisomerase II genes. Yeast. 2002;19(11):973–989. doi:10.1002/yea.89212125054
   PubMed Web of Science ®Google Scholar
• Guo Y, Yang J-X, Liang G-W. A real-time PCR assay based on 5.8S rRNA gene (5.8S rDNA) for rapid detection of Candida from whole blood samples. Mycopathologia. 2016;181(5–6):405–413. doi:10.1007/s11046-015-9977-z26687075
   PubMed Web of Science ®Google Scholar
• Fidler G, Leiter E, Kocsube S, Biro S, Paholcsek M. Validation of a simplex PCR assay enabling reliable identification of clinically relevant Candida species. BMC Infect Dis. 2018;18(1):393. doi:10.1186/s12879-018-3283-630103686
   PubMed Web of Science ®Google Scholar
• Decat E, Van Mechelen E, Saerens B, et al. Rapid and accurate identification of isolates of Candida species by melting peak and melting curve analysis of the internally transcribed spacer region 2 fragment (ITS2-MCA). Res Microbiol. 2013;164(2):110–117. doi:10.1016/j.resmic.2012.10.01723142490
   PubMed Web of Science ®Google Scholar
• Sturaro LL, Gonoi T, Busso-Lopes AF, et al. Visible DNA microarray system as an adjunctive molecular test in identification of pathogenic fungi directly from a blood culture bottle. J Clin Microbiol. 2018;56(5):e01908–01917. doi:10.1128/JCM.01908-1729514940
   PubMed Web of Science ®Google Scholar
• Das S, Brown TM, Kellar KL, Holloway BP, Morrison CJ. DNA probes for the rapid identification of medically important Candida species using a multianalyte profiling system. FEMS Immunol Med Microbiol. 2006;46(2):244–250. doi:10.1111/j.1574-695X.2005.00031.x16487306
   PubMedGoogle Scholar
• Freydiere AM, Buchaille L, Guinet R, Gille Y. Evaluation of latex reagents for rapid identification of Candida albicans and C. krusei colonies. J Clin Microbiology. 1997;35(4):877–880. doi:10.1128/JCM.35.4.877-880.1997
   Web of Science ®Google Scholar
• Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD. Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Front Microbiol. 2017;7:2173. doi:10.3389/fmicb.2016.0217328127295
   PubMed Web of Science ®Google Scholar
• Katiyar SK, Edlind TD. Identification and expression of multidrug resistance-related ABC transporter genes in. Candida Krusei. Med Mycol. 2001;39(1):109–116. doi:10.1080/mmy.39.1.109.11611270397
   PubMed Web of Science ®Google Scholar
• Ricardo E, Miranda IM, Faria-Ramos I, Silva RM, Rodrigues AG, Pina-Vaz C. In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei. Antimicrob Agents Chemother. 2014;58(8):4604–4611. doi:10.1128/AAC.02603-1424867987
   PubMed Web of Science ®Google Scholar
• Gong J, Xiao M, Wang H, et al. Genetic differentiation, diversity, and drug susceptibility of Candida krusei. Front Microbiol. 2018;9:2717. doi:10.3389/fmicb.2018.0271730524386
   PubMed Web of Science ®Google Scholar
• Nguyen KT, Ta P, Hoang BT, et al. Anidulafungin is fungicidal and exerts a variety of postantifungal effects against Candida albicans, C. glabrata, C. parapsilosis, and C. krusei isolates. Antimicrob Agents Chemother. 2009;53(8):3347–3352. doi:10.1128/AAC.01480-0819364856
   PubMed Web of Science ®Google Scholar
• Forastiero A, Garcia-Gil V, Rivero-Menendez O, et al. Rapid development of Candida krusei echinocandin resistance during caspofungin therapy. Antimicrob Agents Chemother. 2015;59(11):6975–6982. doi:10.1128/AAC.01005-1526324281
   PubMed Web of Science ®Google Scholar
• Mendling W. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis). Mycoses. 2015;58(S1):1–15. doi:10.1111/myc.12292
   Web of Science ®Google Scholar
• Locke JB, Almaguer AL, Donatelli JL, Bartizal KF. Time-kill kinetics of rezafungin (CD101) in vagina-simulative medium for fluconazole-susceptible and fluconazole-resistant Candida albicans and non-albicans Candida species. Infect Dis Obstet Gynecol. 2018;2018:7040498. doi:10.1155/2018/704049829681727
   PubMedGoogle Scholar
• Mackie DP, Neill SD, Rodgers SP, Logan EF. Treatment of Candida krusei mastitis with sulphamethoxypyridazine. Vet Rec. 1987;120(2):48. doi:10.1136/vr.120.2.48
   Web of Science ®Google Scholar
• Schell WA, Jones AM, Garvey EP, Hoekstra WJ, Schotzinger RJ, Alexander BD. Fungal CYP51 inhibitors VT-1161 and VT-1129 exhibit strong in vitro activity against Candida glabrata and C. krusei isolates clinically resistant to azole and echinocandin antifungal compounds. Antimicrob Agents Chemother. 2017;61(3):e01817–01816. doi:10.1128/AAC.01817-1627956419
   PubMed Web of Science ®Google Scholar
• Domingues Bianchin M, Borowicz SM, da Rosa Monte Machado G, et al. Lipid core nanoparticles as a broad strategy to reverse fluconazole resistance in multiple Candida species. Colloids Surf B Biointerfaces. 2019;175:523–529. doi:10.1016/j.colsurfb.2018.12.01130579053
   PubMed Web of Science ®Google Scholar
• Wang T, Shao J, Da W, et al. Strong synergism of palmatine and fluconazole/itraconazole against planktonic and biofilm cells of Candida species and efflux-associated antifungal mechanism. Front Microbiol. 2018;9:2892. doi:10.3389/fmicb.2018.0289230559726
   PubMed Web of Science ®Google Scholar
• Patriota LL, Procópio TF, de Souza MF, et al. A Trypsin inhibitor from Tecoma stans leaves inhibits growth and promotes ATP depletion and lipid peroxidation in Candida albicans and Candida krusei. Front Microbiol. 2016;7:611. doi:10.3389/fmicb.2016.0061127199940
   PubMed Web of Science ®Google Scholar
• Bezerra CF, Rocha JE, Nascimento Silva MKD, et al. Analysis by UPLC-MS-QTOF and antifungal activity of guava (Psidium guajava L.). Food Chem Toxicol. 2018;119:122–132. doi:10.1016/j.fct.2018.05.02129751075
   PubMed Web of Science ®Google Scholar
• Souza-Moreira TM, Severi JA, Rodrigues ER, et al. Flavonoids from Plinia cauliflora (Mart.) Kausel (Myrtaceae) with antifungal activity. Nat Prod Res. 2019;33(17):2579–2582. doi:10.1080/14786419.2018.146082729620451
   PubMed Web of Science ®Google Scholar
• Moraes RC, Carvalho AR, Lana AJ, et al. In vitro synergism of a water insoluble fraction of Uncaria tomentosa combined with fluconazole and terbinafine against resistant non-Candida albicans isolates. Pharm Biol. 2017;55(1):406–415. doi:10.1080/13880209.2016.124263127931150
   PubMed Web of Science ®Google Scholar
• Min J, Lee YJ, Kim YA, et al. Lysophosphatidylcholine derived from deer antler extract suppresses hyphal transition in Candida albicans through MAP kinase pathway. Biochim Biophys Acta. 2001;1531(1–2):77–89. doi:10.1016/S1388-1981(01)00088-911278174
   PubMed Web of Science ®Google Scholar
• Nami S, Aghebati-Maleki A, Morovati H, Aghebati-Maleki L. Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases. Biomed Pharmacother. 2019;110:857–868. doi:10.1016/j.biopha.2018.12.00930557835
   PubMed Web of Science ®Google Scholar